Carbamic Acid

Carbamic Acid

SCHEMBL1700994

N.N.NC(=O)O.O=C(O)O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Carbamic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.78
CA2 P00918 2/20 0.56
CA9 Q16790 2/20 0.56
CA1 P00915 1/20 0.56
LMNA P02545 5/20 0.50
ALDH1A1 P00352 4/20 0.50
TDP1 Q9NUW8 4/20 0.50
OR51E2 Q9H255 2/20 0.50
LDHA P00338 2/20 0.50
LDHB P07195 1/20 0.50
BLM P54132 5/20 0.42
PMP22 Q01453 4/20 0.42
ALOX15 P16050 2/20 0.42
CYP3A4 P08684 4/20 0.36
TSHR P16473 4/20 0.36
HSD17B10 Q99714 3/20 0.36
NFKB1 P19838 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 2/20 0.36
THPO P40225 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL6242520 1.00 ACHE (0.78) ACHECA2CA9CA1LMNA
Carbamic Acid SCHEMBL8577148 1.00 ACHE (0.78) ACHECA2CA9CA1LMNA
Carbamic Acid SCHEMBL497132 1.00
Carbamic Acid SCHEMBL6242522 1.00 ACHE (0.78) ACHECA2CA9CA1LMNA
Carbamic Acid SCHEMBL20658763 0.95
Carbamic Acid SCHEMBL453944 0.94
Carbamic Acid SCHEMBL7077007 0.94 ACHE (0.88) ACHECA2CA9CA1LMNA
Carbamic Acid SCHEMBL1356882 0.94
Carbamic Acid SCHEMBL11773571 0.94 ACHE (0.88) ACHECA2CA9CA1LMNA
Carbamic Acid SCHEMBL49149 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118012574-B Virtual machine service condition grading method under private cloud platform 北京计算机技术及应用研究所 2024-08-13 CN claimed
CN-118012574-A Virtual machine service condition grading method under private cloud platform 北京计算机技术及应用研究所 2024-05-10 CN claimed
CN-113698657-A Novel PU coordination substance foaming agent and preparation method thereof 天津市红百丽科工贸有限公司 2021-11-26 CN claimed
US-9534002-B2 Procedures for the synthesis of ethylenediamine bisborane and ammonia borane PURDUE RESEARCH FOUNDATION (US) 2017-01-03 US claimed
US-20130225863-A1 Procedures for the Synthesis of Ethylenediamine Bisborane and Ammonia Borane PURDUE RESEARCH FOUNDATION (US) 2013-08-29 US claimed
WO-2012006347-A2 PROCEDURES FOR THE SYNTHESIS OF ETHYLENEDIAMINE BISBORANE AND AMMONIA BORANE RAMACHANDRAN PADI VEERARAGHAVAN (US) 2012-01-12 WO claimed
US-20030219367-A1 Process for the utilization of vanadium in chromium ore as ammonium metavanadate BAYER AKTIENGESELLSCHAFT (DE) 2003-11-27 US claimed
US-5858337-A TREATING WITH FIRST PERMANENT WAVE COMPOSITION AT PH 4-8 TO CLEAVE S-S BONDS, TREATING WITH CARBONATE OR BICARBONATE COMPOSITION TO CLEAVE MIXED DISULFIDES, TREATING WITH SECOND PERMANENT PACKAGE; PREVENTING DAMAGE TO HAIR KAO CORPORATION (JP) 1999-01-12 US claimed
US-4432915-A Method for producing nuclear fuel pellets, and product thereof GENERAL ELECTRIC COMPANY (US) 1984-02-21 US claimed
US-4383953-A Method of improving the green strength of nuclear fuel pellets GENERAL ELECTRIC COMPANY (US) 1983-05-17 US claimed
US-4190503-A ELECTROLESS DEPOSITION OF NICKEL IN PRESENCE OF LACTIC ACID SONY CORPORATION (JP) 1980-02-26 US claimed
US-4138360-A Fugitive binder for nuclear fuel materials GENERAL ELECTRIC COMPANY (US) 1979-02-06 US claimed
US-4076654-A AMMONIA GENERATING COMPOUND BRIDGESTONE TIRE COMPANY LIMITED (JA) 1978-02-28 US claimed
US-4061700-A Fugitive binder for nuclear fuel materials GENERAL ELECTRIC COMPANY (US) 1977-12-06 US claimed
EP-3819686-B1 OPTICAL MODULATION ELEMENT LG CHEMICAL LTD (KR) 2025-12-03 EP disclosed
CN-115434147-B Anti-falling Mao Shanhu velvet fabric and preparation method thereof 菏泽市源林川服饰有限公司 2024-02-13 CN disclosed
CN-113728056-B Latent heat storage material 株式会社钟化 2023-03-24 CN disclosed
US-4076654-A AMMONIA GENERATING COMPOUND BRIDGESTONE TIRE COMPANY LIMITED (JA) 1978-02-28 US disclosed
US-4061700-A Fugitive binder for nuclear fuel materials GENERAL ELECTRIC COMPANY (US) 1977-12-06 US disclosed
US-4061700-A Fugitive binder for nuclear fuel materials GENERAL ELECTRIC COMPANY (US) 1977-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225863-A1 Procedures for the Synthesis of Ethylenediamine Bisborane and Ammonia Borane NAAA, ALKBH1, BTD ACHE 3483/4885CA2 111/4885CA9 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.